epirubicin has been researched along with Bile Duct Cancer in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 6 (60.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuvertoret-Sanz, M; Marco, A; Martínez, J; Martínez-Sogues, L; Novellas, R; Pastor, J; Roura, X; Solano-Gallego, L; Vila, A | 1 |
Pawlega, J; Zygulska, AL | 1 |
Hori, Y; Kiyosue, H; Komatsu, E; Matsumoto, A; Matsumoto, S; Mori, H; Tomonari, K; Wakisaka, M | 1 |
Hoki, M; Hori, S; Ito, T; Iwase, K; Kainuma, S; Kanou, T; Mizuno, H; Mizushima, T; Nakamori, Y; Ozawa, H; Souma, Y; Sugiura, T; Yamanaka, H | 1 |
Chuang, WL; Chuang, YH; Hsieh, MY; Lin, ZY; Tsai, JF; Wang, LY; Yu, ML | 1 |
Chen, Y; Cheng, JM; Gong, GQ; Liu, QX; Liu, R; Luo, JJ; Qian, S; Wang, JH; Wang, XL; Yan, ZP | 1 |
Imai, M; Katsuki, Y; Nishimura, A; Tsuji, Y; Yasuda, T | 1 |
Kajanti, M; Pyrhönen, S | 1 |
Lauchart, W; Pirschel, J | 1 |
Fukushima, Y; Fuzita, J; Hata, S; Hayashida, H; Ikeda, K; Ishida, T; Kitada, M; Nakamura, T; Niinobu, T; Shibata, T; Shimano, T; Suzuki, R; Takahashi, Y; Takami, M; Tukahara, Y | 1 |
2 trial(s) available for epirubicin and Bile Duct Cancer
Article | Year |
---|---|
[Assessment of the value of PEF (cisplatin, epirubicin, 5 fluorouracil) in advanced extrahepatic biliary tract and pancreatic cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Cisplatin; Deoxycytidine; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Palliative Care; Pancreatic Neoplasms; Prognosis; Survival Rate | 2008 |
Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system. A phase II study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Biliary Tract Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Survival Analysis | 1994 |
8 other study(ies) available for epirubicin and Bile Duct Cancer
Article | Year |
---|---|
Hypercalcemia of Malignancy in a Dog Diagnosed With Cholangiocellular Carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Cholangiocarcinoma; Dog Diseases; Dogs; Epirubicin; Hypercalcemia; Male; Paraneoplastic Syndromes; Parathyroid Hormone-Related Protein; Prednisone | 2019 |
Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Combined Modality Therapy; Epinephrine; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Liver; Male; Middle Aged; Mitomycin; Prognosis; Radiotherapy, Conformal; Survival Rate; Treatment Outcome; Vasoconstrictor Agents | 2004 |
[A case of postoperative liver metastasis from bile duct carcinoma responding to transarterial chemoembolization].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemoembolization, Therapeutic; Drug Administration Schedule; Epirubicin; Fluorouracil; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Polymers; Postoperative Period; Remission Induction | 2006 |
Discordant influence of amphotericin B on epirubicin cytotoxicity in primary hepatic malignant cells collected by a new primary culture technique.
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biopsy, Fine-Needle; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Proliferation; Cholangiocarcinoma; Drug Interactions; Drug Therapy, Combination; Epirubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Treatment Outcome; Tumor Cells, Cultured | 2006 |
[Epirubicin in the treatment of malignant obstructive jaundice].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bilirubin; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Jaundice, Obstructive; Liver Neoplasms; Male; Middle Aged; Recurrence; Survival Rate | 2006 |
[A case of liver metastasis from bile duct cancer effectively treated with hepatic artery infusion chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Mitomycin | 1994 |
[Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol].
Topics: Adenoma, Bile Duct; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Epirubicin; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects | 1993 |
[Transcatheter arterial chemo-embolization using degradable starch microspheres (DSM) markedly effective for post-hepatectomy intra-hepatic recurrence in a patient with cholangioma].
Topics: Aged; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Epirubicin; Hepatectomy; Humans; Liver Neoplasms; Male; Microspheres; Mitomycin; Neoplasm Recurrence, Local; Postoperative Period; Starch | 2000 |